Clemens Gillen Selected Research

Small Interfering RNA (siRNA)

11/2006

Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clemens Gillen Research Topics

Disease

6	Pain (Aches) 03/2005 - 02/2002
2	Hyperalgesia 11/2006 - 03/2005
1	Hypersensitivity (Allergy) 01/2007
1	Neuralgia (Stump Neuralgia) 01/2007
1	Visceral Pain 11/2006
1	Atrophy 03/2005
1	Cystitis 08/2003
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 08/2003
1	Chronic Pain 09/2002

Drug/Important Bio-Agent (IBA)

3	Analgesics (Analgesic Drugs)IBA 01/2007 - 09/2002
2	TRPV Cation ChannelsIBA 01/2007 - 11/2006
2	Messenger RNA (mRNA)IBA 01/2007 - 03/2005
1	Antisense OligonucleotidesIBA 01/2007
1	OligonucleotidesIBA 01/2007
1	Capsaicin (Zostrix)FDA Link 11/2006
1	Small Interfering RNA (siRNA)IBA 11/2006
1	PlasticsIBA 03/2005
1	Proteins (Proteins, Gene)FDA Link 03/2005
1	NociceptinIBA 03/2004
1	LigandsIBA 03/2004
1	NeuropeptidesIBA 03/2004
1	Opioid Receptors (Opioid Receptor)IBA 03/2004
1	Nociceptin ReceptorIBA 03/2004
1	alpha,beta-methyleneadenosine 5'-triphosphateIBA 08/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2003
1	Chloral HydrateIBA 05/2003
1	Trichloroethylene (Trichloroethene)IBA 05/2003
1	ChloridesIBA 02/2002

Therapy/Procedure

1	Ligation 01/2007
1	Spinal Injections 11/2006
1	Therapeutics 09/2002